PDL BioPharma, Inc. Dividend Yield

Dividend Yield of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Dividend Yield growth rates and interactive chart. The dividend yield is the ratio of a company's annual dividend per share compared to its share price. It is also calculated as the total amount of dividends divided by the market capitalization. The dividend yield is represented as a percentage.


Highlights and Quick Summary

Current Dividend Yield of PDL BioPharma, Inc. is 0.0% (as of December 30, 2019)
  • Dividend Yield for the quarter ending June 29, 2020 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Dividend Yield decreased by -100.0%
  • Annual Dividend Yield for 2019 was 0.0% (a -100.0% decrease from previous year)
  • Annual Dividend Yield for 2018 was 0.01% (a -80.0% decrease from previous year)
  • Annual Dividend Yield for 2017 was 0.05% (a -98.9% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Dividend Yield of PDL BioPharma, Inc.

Most recent Dividend Yieldof PDLI including historical data for past 10 years.

Interactive Chart of Dividend Yield of PDL BioPharma, Inc.

PDL BioPharma, Inc. Dividend Yield for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.0% 0.0%
2019 0.0% 0.02% 0.01% 0.01% 0.0%
2018 0.01% 0.06% 0.06% 0.05% 0.01%
2017 0.05% 0.03% 0.04% 2.25% 0.05%
2016 4.54% 7.49% 12.77% 15.04% 4.54%
2015 17.0% 11.92% 9.28% 8.47% 17.0%
2014 7.92% 7.78% 5.81% 6.93% 7.92%
2013 7.12% 7.54% 7.7% 8.18% 7.12%
2012 8.53% 7.63% 8.93% 9.28% 8.53%
2011 9.73% 17.16% 13.68% 18.63% 9.73%
2010 0.0% 0.0% 0.0% 0.0%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.